Symbol="OCGN"
AssetType="Common Stock"
Name="Ocugen Inc"
Description="Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the development of gene therapies to cure diseases of blindness. The company is headquartered in Malvern, Pennsylvania."
CIK="1372299"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="5 GREAT VALLEY PARKWAY, SUITE 160, MALVERN, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="143601000"
EBITDA="-84007000"
PERatio="None"
PEGRatio="None"
BookValue="0.335"
DividendPerShare="0"
DividendYield="0"
EPS="-0.4"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.444"
ReturnOnEquityTTM="-0.772"
RevenueTTM="-380"
GrossProfitTTM="-49757000"
DilutedEPSTTM="-0.4"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="3.9"
TrailingPE="-"
ForwardPE="15.22"
PriceToSalesRatioTTM="25069.32"
PriceToBookRatio="3.652"
EVToRevenue="35591.28"
EVToEBITDA="-3.362"
Beta="3.642"
num_52WeekHigh="3.07"
num_52WeekLow="0.44"
num_50DayMovingAverage="0.583"
num_200DayMovingAverage="1.123"
SharesOutstanding="256430000"
DividendDate="2019-09-30"
ExDividendDate="None"
symbol="OCGN"
open="0.55"
high="0.56"
low="0.54"
price="0.56"
volume="5193822.00"
latest_trading_day="2023-07-07"
previous_close="0.54"
change="0.02"
change_percent="3.7229%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="7523841"
Change_recent_avg="-0.01"
Delta_recent_avg="0.05"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-0.97"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="167"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0009.jpeg"
image_negative_thumbnail_id_2="1088"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0121.jpeg"
image_neutral_thumbnail_id_1="584"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0015.jpeg"
image_neutral_thumbnail_id_2="583"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_positive_thumbnail_id_1="628"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0080.jpeg"
image_positive_thumbnail_id_2="965"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0127.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
